Search for: "Raymond Adams"
Results 261 - 268
of 268
Sorted by Relevance
|
Sort by Date
12 Dec 2021, 2:22 pm
In assessing an association for causality, the starting point is “an association between two variables, perfectly clear-cut and beyond what we would care to attribute to the play of chance. [read post]
17 Sep 2019, 1:26 am
However in so far as they seek to declare it “null” and of “no effect” he submits that they went too far and where they cannot go. 14:16: Lord Keen QC notes that this principle is consistent with extensive authority and which Sir James Eadie QC will address in due course in further detail. 14:14: Lord Keen QC notes that the Inner House accepted that the principle of non-justiciability exists in public law and that the question of whether something is… [read post]
30 Sep 2022, 4:00 am
The former president’s legal team told Judge Raymond Dearie, who is reviewing the [read post]
10 Sep 2010, 8:07 am
Raymond Corp., 340 F.3d 520, 524-25 (8th Cir. 2003); Dancy v. [read post]
28 Sep 2020, 10:02 am
Panelists Adam Day, director of programmes at United Nations University; Vanda Felbab-Brown, Brookings senior fellow; Payton Knopf, senior advisor for the U.S. [read post]
10 Oct 2020, 2:23 pm
Adam Schiff is no friend to the Trump Administration (e.g., here). [read post]
1 Aug 2011, 5:41 am
Eigen and Adam Seth Litwin Northwestern University School of Law and affiliation not provided to SSRN , Johns Hopkins Abstract: Until now, empirical research has been unable to reliably identify the impact of organizational dispute resolution systems (DRSs) on the workforce at large, in part because of the dearth of data tracking employee perceptions pre- and post- implementation. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
